Pamela Zizzamia

Endocrinology in Enfield, Connecticut

Practice Details

Address
146 Hazard Ave Ste 107
Enfield, CT 06082
Geocoded location: 41.9879, -72.5600
Taxonomy
Endocrinology, Diabetes & Metabolism
Credential
D.O.
NPPES Enumeration
Listed with NPPES since 2013
Sole Proprietor
Yes
Provider Gender (NPPES)
Female
Also Listed As
Pamela Ohri
NPPES Record Updated
December 2023

Specialty taxonomies on file (2)

  • Internal Medicine
  • Endocrinology
    Internal Medicine, Endocrinology, Diabetes & Metabolism
    Primary

All specialty taxonomies this NPI reports in the CMS National Provider registry. A taxonomy on file reflects a self-reported designation, not confirmation of current services.

About This Clinician

This clinician is enumerated under Endocrinology, Diabetes & Metabolism. Endocrinologists treat hormonal and metabolic conditions including type 2 diabetes, and frequently prescribe GLP-1 medications such as semaglutide or tirzepatide as part of diabetes or metabolic-syndrome management — though not every endocrinology practice treats obesity as a primary focus, and some see only referred, complex cases.

Locally, this is 1 of 4 Endocrinology, Diabetes & Metabolism practices in Enfield carrying this exact taxonomy in our directory.

What to expect at an Endocrinology visit

Endocrinology visits focus on hormonal and metabolic conditions. For a GLP-1-related consult, patients commonly encounter:

  • •A review of diabetes, thyroid, or metabolic history and current medications.
  • •Lab work such as A1c and a metabolic panel to guide diagnosis and dosing.
  • •A discussion of whether a GLP-1 medication fits the treatment goal (diabetes control, weight, or both).
  • •Follow-up scheduling to titrate dose and monitor response over time.

This is general guidance for endocrinology practices, not a description of Pamela Zizzamia's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 860-386-5167.

GLP-1 access in Enfield, Connecticut

Adult obesity rate
29.1%
#41 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$224/mo
Typical Connecticut telehealth cash price
Medicaid GLP-1 coverage
Diabetes + obesity (with prior auth)
Connecticut Medicaid, obesity indication

About 29.1% of Connecticut adults have obesity (BMI 30+), ranking the state #41 of 50 (CDC BRFSS). Our directory currently lists 7 GLP-1-relevant clinics in Enfield. If a cash-pay route makes more sense, compounded semaglutide through Connecticut telehealth averages about $224/mo — well below brand-name Wegovy or Zepbound.

Explore more Connecticut options on the best Connecticut GLP-1 providers page, browse every Enfield listing in the Enfield clinic directory.

Related Practices in Enfield

Other Enfield listings in the same directory tier:

Monarch Metabolic and Hormonal Health, PLLC
Endocrinology
Monarch Endocrinology, PLLC
Endocrinology
Molly Emott
Endocrinology

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to Connecticut addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured Connecticut telehealth partners:

Featured Partners · Enfield

Featured GLP-1 providers serving Enfield

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick
    7.6
    Maximus

    Compounded from

    $249.99/mo

    Save $1,099.01/mo vs Wegovy
    Get started →
  2. 8.3
    Found

    Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. 7.4
    Breeze Meds

    Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. 6.2
    Wellorithm

    Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 8.2
    Gala

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  6. 6.9
    TMates

    Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →
See all 172 GLP-1 providers serving Enfield ↓

See more Enfield options on the Enfield clinic directory, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Enfield obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Pamela Zizzamia's specialty taxonomy but not the specific medications it prescribes or its current service menu. Pamela Zizzamia is listed under Endocrinology, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 860-386-5167 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Pamela Zizzamia's primary specialty on file is Endocrinology.
Pamela Zizzamia is located at 146 Hazard Ave Ste 107, Enfield, CT 06082. The phone number listed in the registry is 860-386-5167. Its full record is public in the CMS National Provider registry under NPI 1568809416.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Pamela Zizzamia is currently accepting new patients. Call the practice at 860-386-5167 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.